Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion-Reference-Cited by-同舟云学术

Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion

Published:2024-07 Issue:4 Volume:11 Page:
ISSN:2332-7812
Container-title:Neurology Neuroimmunology & Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Gawde Saurabh¹,Siebert Nadja¹^ORCID,Ruprecht Klemens¹^ORCID,Kumar Gaurav¹,Ko Rose M.¹,Massey Kaylea¹,Guthridge Joel M.¹,Mao-Draayer Yang¹,Schindler Patrick¹,Hastermann Maria¹^ORCID,Pardo Gabriel¹^ORCID,Paul Friedemann¹^ORCID,Axtell Robert C.¹^ORCID

Affiliation:

1. From the Arthritis and Clinical Immunology Research Program (S.G., G.K., R.M.K., K.M., J.M.G., Y.M.-D., G.P., R.C.A.), Oklahoma Medical Research Foundation; Department of Microbiology and Immunology (S.G., R.C.A.), Oklahoma University Health Science Center; NeuroCure Clinical Research Center and Experimental and Clinical Research Center (N.S., K.R., P.S., M.H., F.P.), Max Delbrueck Center for Molecular Medicine and Charité Universitätsmedizin Berlin; and Department of Neurology (N.S., K.R., P.S., M...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200268

Reference51 articles.

1. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

2. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

3. Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica

4. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

5. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders